Home > Insider Trading > Filing (0000890465-13-000025)

Filing Details

Accession Number:: 0000890465-13-000025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-30 18:23:38
Reporting Period:: 2013-09-26

Filing Date:: 2013-09-30
Accepted Time:: 2013-09-30 18:23:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890465	Nps Pharmaceuticals Inc	NPSP	Biological Products, (No Disgnostic Substances) (2836)	870439579

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365343	Francois Nader	550 Hills Drive Bedminster NJ 07921	President, Ceo And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-09-26	19,350	$5.05	236,828	No	4	M	Direct
Common Stock	Acquisiton	2013-09-26	992	$5.85	237,820	No	4	M	Direct
Common Stock	Disposition	2013-09-26	143,503	$33.07	94,317	No	4	S	Direct
Common Stock	Disposition	2013-09-26	6,497	$33.60	87,820	No	4	S	Direct
Common Stock	Acquisiton	2013-09-27	17,008	$5.85	104,828	No	4	M	Direct
Common Stock	Acquisiton	2013-09-27	16,650	$6.16	121,478	No	4	M	Direct
Common Stock	Acquisiton	2013-09-27	9,800	$5.71	131,278	No	4	M	Direct
Common Stock	Disposition	2013-09-27	43,458	$32.36	87,820	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2013-09-26	19,350	$0.00	19,350	$5.05
Common Stock	Stock Options	Disposition	2013-09-26	992	$0.00	992	$5.85
Common Stock	Stock Options	Disposition	2013-09-27	17,008	$0.00	17,008	$5.85
Common Stock	Stock Options	Disposition	2013-09-27	16,650	$0.00	16,650	$6.16
Common Stock	Stock Options	Disposition	2013-09-27	9,800	$0.00	9,800	$5.71

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,150	2018-07-15	No	4	M	Direct
21,508	2018-10-15	No	4	M	Direct
4,500	2018-10-15	No	4	M	Direct
5,850	2019-01-15	No	4	M	Direct
82,826	2019-01-20	No	4	M	Direct

Footnotes

The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective September 26, 2013.
The price shown above represents the weighted average price of the shares sold. The range of sales prices was $32.51 and $33.50. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
The price shown above represents the weighted average price of the shares sold. The range of sales prices was $33.52 and $33.69. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
The price shown above represents the weighted average price of the shares sold. The range of sales prices was $32.05 and $32.77. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
On July 15, 2008, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter.
On October 15, 2008, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter.
On January 15, 2009, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter.
On January 20, 2009, the Reporting Person received a grant of performance based options under the Issuer's 1998 Stock Option Plan. The actual number of options received was 92,626, which was determined based on the performance of the Issuer's common stock relative to the performance of stock comprising a selected market index. 50% of such options vested and became exercisable on the second anniversary of the date of grant and the remaining 50% of such options vested and became exercisable on the third anniversary of the date of grant.